Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3 (2019 Conference) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint

Sajad Zalzala, MD - What Patients Need to Know About Telemedicine (2019 Conference) (LDN, low dose naltrexone)

Sajad Zalzala, MD discusses what telemedicine is, its use and benefits, and about using LDN Direct telemedicine/LDN prescription business. Some telemedicine regulations are presented, as well as common conditions treated with LDN

Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under-Appreciated (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

Igor Schwartzman, ND - The Art of LDN Prescribing In Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

Igor Schwartzman, ND discusses the use of LDN in Hashimoto’s thyroiditis. He presents clinical characteristics, symptoms, and diagnostic criteria; possible causes, forms of thyroiditis, when LDN would benefit, dosing, and when to stop LDN.

Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: When TSH is Normal but Reverse T3 is Elevated (2019 Conference) (LDN, low dose naltrexone)

Carrie Jones, ND, MPH discusses LDN and hypothyroidism at the LDN 2019 Conference. She discusses the thyroid hormone cycle, deiodinase enzymes that affect thyroid hormones, and LDN’s mechanism of action related to thyroid functioning.